中國海外宏洋集團(00081.HK)擬1953.87萬元收購合肥多個辦公室單位
格隆匯 4 月 1日丨中國海外宏洋集團(00081.HK)宣佈,公司全資附屬中海宏洋地產(合肥)有限公司作為買方於2021年3月8日與賣方訂立買賣協議,正式落實有關位於中國合肥市包河區龍川路以北、西遞路以東萬錦花園S1座的18個辦公室單位(即物業)的一系列收購,總代價為人民幣1953.87萬元。
據悉,賣方為一家分別由中海宏洋附屬公司(公司的間接全資附屬公司)及中建宏達(中國建築國際的間接全資附屬公司)各自擁有45%,以及由賽富興合附屬公司擁有10%的合營企業。
物業為賣方擁用的發展項目之存貨(即位於中國合肥市包河區的一幅土地上之商業和住宅物業)。公司藉此機會購入可符合公司需求的辦公室供其自用,而不必如現時在合肥租用辦公室。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.